Back to Archived Journals » Virus Adaptation and Treatment » Volume 2

An update on small molecule inhibitors of the HCV NS5B polymerase: effects on RNA synthesis in vitro and in cultured cells, and potential resistance in viral quasispecies

Authors Chinnaswamy S, Cai H, Kao C

Published 22 June 2010 Volume 2010:2 Pages 73—89


Review by Single anonymous peer review

Peer reviewer comments 4

S Chinnaswamy, H Cai, C Kao

Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN, USA

Abstract: Chronic infection by the hepatitis C virus (HCV) can lead to liver cirrhosis and hepatocellular carcinoma. There is currently no prophylactic vaccine against HCV, and the treatment is currently limited to modified interferon and ribavirin. The RNA-dependent RNA polymerase (RdRp) of HCV is an attractive target for inhibitor development, and this has led to active efforts in the development of nucleoside and non-nucleoside inhibitors. The HCV polymerase is also one of the model systems for detailed analysis of how RdRp structure affects the mechanism of RNA synthesis. This review summarizes current efforts with inhibitors targeting the HCV RdRp and how the various inhibitors affect the mechanism of RNA synthesis.

Keywords: HCV infection, RdRp, nucleoside inhibitors, subgenomic replicons, ProTides, ribavirin, allosteric site

Creative Commons License © 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.